Treating sleep problems in young people at ultra-high-risk of psychosis: a single-blind parallel-group randomised controlled feasibility trial (SleepWell)

niversity of Oxford0 个研究点目标入组 40 人开始时间: 2020年9月8日最近更新: 2023年8月28日

试验速览

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37562423/ (added 14/08/2023)

•1. Aged 14-25 years
•2. Patient of mental health services (at the time of referral to the study)
•3. Meet diagnostic criteria for ultra-high-risk of psychosis on the Comprehensive Assessment of At-Risk-Mental States
•4. Experiencing current sleep problems (defined as a score >15 on the Insomnia Severity Index)
•5. Would like help to improve sleep
•6. Participant is willing and able to give informed consent (or assent with parent/guardian consent for participants aged 14-15 years) for participation in the trial

•1. Diagnosis of a primary severe mental health problem (including psychosis, bipolar disorder, personality disorder)
•2. A primary diagnosis of alcohol/substance dependency, organic syndrome or learning disability
•3. Likely primary diagnosis of sleep apnoea (established using the STOP-BANG screen)
•4. Current engagement in any other individual psychological therapy
•A participant may also not enter the trial if there is another factor (for example, current active suicidal plans, high risk for severe course of COVID-19), which, in the judgement of the investigator, would preclude the participant from providing informed consent or from safely engaging with the trial procedures

发起方